Financials
- Market Capitalization 449.1 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.47
市销率
2.71
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2968 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.33 USD | -4.20% | -6.68% | -17.05% | +283.19% | 461.88 M USD | ||
| 2981 | AGMB AgomAb Therapeutics NV - ADRs representing one | 13.17 USD | -4.84% | -0.30% | +3.70% | -10.41% | 449.98 M USD | ||
| 2984 | OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -3.65% | -6.38% | +8.20% | +30.69% | 447.63 M USD | ||
| 2988 | RZLT Rezolute, Inc. - Common Stock | 4.62 USD | -7.23% | -8.15% | -2.12% | -35.11% | 444.87 M USD |